TNSN04250A1 - Diphenyl azetidinones substituted by acidic groups, method for their production, medicaments containing said compounds and use thereof. - Google Patents

Diphenyl azetidinones substituted by acidic groups, method for their production, medicaments containing said compounds and use thereof.

Info

Publication number
TNSN04250A1
TNSN04250A1 TNP2004000250A TNSN04250A TNSN04250A1 TN SN04250 A1 TNSN04250 A1 TN SN04250A1 TN P2004000250 A TNP2004000250 A TN P2004000250A TN SN04250 A TNSN04250 A TN SN04250A TN SN04250 A1 TNSN04250 A1 TN SN04250A1
Authority
TN
Tunisia
Prior art keywords
compounds
production
acidic groups
medicaments containing
substituted
Prior art date
Application number
TNP2004000250A
Inventor
Werner Kramer
Stefanie Flohr
Andreas Lindenschmidt
Heiner Glombik
Hubert Heuer
Hans-Ludwig Schaefer
Gerhard Jaehne
Wendelin Frick
Original Assignee
Aventis Pharma Deutschland Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Deutschland Gmbh filed Critical Aventis Pharma Deutschland Gmbh
Publication of TNSN04250A1 publication Critical patent/TNSN04250A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/568—Four-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Obesity (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

The invention relates to compounds of formula (I); in which R1; R2; R3; R4; R5 and R6 are defined as cited; in addition to their physiologically compatible salts. The compounds are suitable for use e.g. as hypolipidaemics.
TNP2004000250A 2002-06-19 2004-12-16 Diphenyl azetidinones substituted by acidic groups, method for their production, medicaments containing said compounds and use thereof. TNSN04250A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10227508A DE10227508A1 (en) 2002-06-19 2002-06-19 Acid group-substituted diphenylazetidinones, processes for their preparation, pharmaceutical compositions containing them and their use
PCT/EP2003/005816 WO2004000805A1 (en) 2002-06-19 2003-06-04 Diphenyl azetidinones substituted by acidic groups, method for their production, medicaments containing said compounds and use thereof

Publications (1)

Publication Number Publication Date
TNSN04250A1 true TNSN04250A1 (en) 2007-03-12

Family

ID=29719283

Family Applications (1)

Application Number Title Priority Date Filing Date
TNP2004000250A TNSN04250A1 (en) 2002-06-19 2004-12-16 Diphenyl azetidinones substituted by acidic groups, method for their production, medicaments containing said compounds and use thereof.

Country Status (29)

Country Link
EP (1) EP1517891B1 (en)
JP (1) JP2005533073A (en)
KR (1) KR20050008835A (en)
CN (1) CN100467448C (en)
AR (1) AR039690A1 (en)
AU (1) AU2003238210B2 (en)
BR (1) BR0311896A (en)
CA (1) CA2490112A1 (en)
DE (1) DE10227508A1 (en)
EC (1) ECSP045497A (en)
HK (1) HK1079511A1 (en)
HN (1) HN2003000185A (en)
HR (1) HRPK20041201B3 (en)
IL (1) IL165789A0 (en)
MA (1) MA27206A1 (en)
MX (1) MXPA04012093A (en)
NO (1) NO20050134L (en)
OA (1) OA12869A (en)
PA (1) PA8576101A1 (en)
PE (1) PE20040564A1 (en)
PL (1) PL372700A1 (en)
RS (1) RS108404A (en)
RU (1) RU2287522C2 (en)
SV (1) SV2004001548A (en)
TN (1) TNSN04250A1 (en)
TW (1) TW200413311A (en)
UA (1) UA78577C2 (en)
UY (1) UY27853A1 (en)
WO (1) WO2004000805A1 (en)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0215579D0 (en) 2002-07-05 2002-08-14 Astrazeneca Ab Chemical compounds
US7871998B2 (en) 2003-12-23 2011-01-18 Astrazeneca Ab Diphenylazetidinone derivatives possessing cholesterol absorption inhibitory activity
CA2589483C (en) 2004-12-03 2013-10-29 Schering Corporation Substituted piperazines as cb1 antagonists
EP1865947A1 (en) * 2005-04-04 2007-12-19 Pontificia Universidad Catolica de Chile The use of ezetimibe in the prevention and treatment of cholesterol gallstones
KR20080021082A (en) 2005-06-20 2008-03-06 쉐링 코포레이션 Piperidine derivatives useful as histamine h3 antagonists
SA06270191B1 (en) 2005-06-22 2010-03-29 استرازينيكا ايه بي Novel 2-Azetidinone Derivatives as Cholesterol Absorption Inhibitors for the Treatment of Hyperlipidaemic Conditions
AR060623A1 (en) 2006-04-27 2008-07-02 Astrazeneca Ab COMPOUNDS DERIVED FROM 2-AZETIDINONE AND A PREPARATION METHOD
WO2007150010A2 (en) * 2006-06-23 2007-12-27 Abbott Laboratories Cyclopropyl amine derivatives as histamin h3 receptor modulators
WO2008017381A1 (en) 2006-08-08 2008-02-14 Sanofi-Aventis Arylaminoaryl-alkyl-substituted imidazolidine-2,4-diones, processes for preparing them, medicaments comprising these compounds, and their use
DE102007002260A1 (en) 2007-01-16 2008-07-31 Sanofi-Aventis Use of substituted pyranonic acid derivatives for the preparation of medicaments for the treatment of the metabolic syndrome
EP2025674A1 (en) 2007-08-15 2009-02-18 sanofi-aventis Substituted tetra hydro naphthalines, method for their manufacture and their use as drugs
CN101200443B (en) * 2007-10-17 2011-06-29 中国药科大学 Nitrogen heterocyclic methyl ethyl ketone derivatives, preparation method and medicine combination containing the same
DE102007063671A1 (en) 2007-11-13 2009-06-25 Sanofi-Aventis Deutschland Gmbh New crystalline diphenylazetidinone hydrates, medicaments containing these compounds and their use
TW201014822A (en) 2008-07-09 2010-04-16 Sanofi Aventis Heterocyclic compounds, processes for their preparation, medicaments comprising these compounds, and the use thereof
WO2010068601A1 (en) 2008-12-08 2010-06-17 Sanofi-Aventis A crystalline heteroaromatic fluoroglycoside hydrate, processes for making, methods of use and pharmaceutical compositions thereof
EP2403848A1 (en) 2009-03-06 2012-01-11 Lipideon Biotechnology AG Pharmaceutical hypocholesterolemic compositions
CN101993403B (en) 2009-08-11 2012-07-11 浙江海正药业股份有限公司 Azetidinone compound and medical applications thereof
SG178880A1 (en) 2009-08-26 2012-04-27 Sanofi Sa Novel crystalline heteroaromatic fluoroglycoside hydrates, pharmaceuticals comprising these compounds and their use
US8933024B2 (en) 2010-06-18 2015-01-13 Sanofi Azolopyridin-3-one derivatives as inhibitors of lipases and phospholipases
WO2012120054A1 (en) 2011-03-08 2012-09-13 Sanofi Di- and tri-substituted oxathiazine derivates, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof
EP2683699B1 (en) 2011-03-08 2015-06-24 Sanofi Di- and tri-substituted oxathiazine derivates, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof
WO2012120052A1 (en) 2011-03-08 2012-09-13 Sanofi Oxathiazine derivatives substituted with carbocycles or heterocycles, method for producing same, drugs containing said compounds, and use thereof
US8828995B2 (en) 2011-03-08 2014-09-09 Sanofi Branched oxathiazine derivatives, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof
WO2012120056A1 (en) 2011-03-08 2012-09-13 Sanofi Tetrasubstituted oxathiazine derivatives, method for producing them, their use as medicine and drug containing said derivatives and the use thereof
EP2567959B1 (en) 2011-09-12 2014-04-16 Sanofi 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5631365A (en) * 1993-09-21 1997-05-20 Schering Corporation Hydroxy-substituted azetidinone compounds useful as hypocholesterolemic agents
DE10042447A1 (en) * 2000-08-29 2002-03-28 Aventis Pharma Gmbh Vertebrate intestinal protein that absorbs cholesterol and use of this protein to identify inhibitors of intestinal cholesterol transport
IL156552A0 (en) * 2000-12-21 2004-01-04 Aventis Pharma Gmbh Diphenyl azetidinone derivatives, method for the production thereof, medicaments containing these compounds, and their use
AU2002231688A1 (en) * 2000-12-21 2002-07-01 Sanofi-Aventis Deutschland Gmbh Diphenyl azetidinone derivatives, method for the production thereof, medicaments containing these compounds, and their use
ES2277890T3 (en) * 2000-12-21 2007-08-01 Sanofi-Aventis Deutschland Gmbh NEW DIFENILAZETIDINONES, PROCEDURE FOR THE PREPARATION, MEDICATIONS CONTAINING THESE COMPOUNDS AND THEIR USE FOR THE TREATMENT OF LIPID METABOLISM DISORDERS.

Also Published As

Publication number Publication date
PE20040564A1 (en) 2004-10-25
AU2003238210A1 (en) 2004-01-06
RS108404A (en) 2007-02-05
AR039690A1 (en) 2005-03-09
TW200413311A (en) 2004-08-01
HRPK20041201B3 (en) 2006-12-31
RU2005101093A (en) 2005-07-20
UA78577C2 (en) 2007-04-10
DE10227508A1 (en) 2004-01-08
OA12869A (en) 2006-09-15
IL165789A0 (en) 2006-01-15
EP1517891B1 (en) 2013-04-03
HK1079511A1 (en) 2006-04-07
NO20050134D0 (en) 2005-01-11
KR20050008835A (en) 2005-01-21
ECSP045497A (en) 2005-03-10
CN100467448C (en) 2009-03-11
HRP20041201A2 (en) 2005-08-31
SV2004001548A (en) 2004-03-19
WO2004000805A1 (en) 2003-12-31
NO20050134L (en) 2005-03-18
CN1662495A (en) 2005-08-31
HN2003000185A (en) 2005-10-20
AU2003238210B2 (en) 2008-10-23
UY27853A1 (en) 2003-12-31
PA8576101A1 (en) 2004-02-07
PL372700A1 (en) 2005-07-25
MXPA04012093A (en) 2005-04-19
MA27206A1 (en) 2005-01-03
RU2287522C2 (en) 2006-11-20
CA2490112A1 (en) 2003-12-31
JP2005533073A (en) 2005-11-04
EP1517891A1 (en) 2005-03-30
BR0311896A (en) 2005-04-05

Similar Documents

Publication Publication Date Title
TNSN04250A1 (en) Diphenyl azetidinones substituted by acidic groups, method for their production, medicaments containing said compounds and use thereof.
ZA200409379B (en) Cationically substituted diphenyl azetidinones, method for their production, medicaments containing said compounds and use thereof
SE0301010D0 (en) Novel compounds
SE0200920D0 (en) Novel compounds
YU46903A (en) Diphenyl azetidinone derivatives, method for the production thereof, medicaments containing these compounds and their use
SE0301009D0 (en) Novel compounds
YU47803A (en) Diphenyl azetidinone derivatives, method for the production thereof, medicaments containing these compounds, and their use
MX2007003108A (en) Substituted bicyclic imidazo-3-ylamine compounds.
TNSN06409A1 (en) Novel fluoroglycoside derivatives of pyrazoles, medicaments containing these compounds, and the use thereof
RS115004A (en) Novel thiophenylglycoside derivatives,methods for production thereof, medicaments comprising said compounds and use thereof
TW200621777A (en) New dihydropteridione derivatives, process for their manufacture and their use as medicament
TW200602338A (en) Selected CGRP antagonists, process for preparing them and their use as pharmaceutical compositions
TW200621262A (en) New dihydropteridione derivatives, process for their manufacture and their use as medicament
TW200519075A (en) Novel compounds
ATE433447T1 (en) PYRIMIIDINE COMPOUNDS
HRP20050870A2 (en) Novel diphenyl azetidinone with improved physiological characteristics, corresponding production method, medicaments containing said compound and use of the latter
ES2368594T3 (en) SUBSTITUTED DERIVATIVES OF CYCLOHEXILMETILO.
NO20063062L (en) Imidazole derivatives, processes for their preparation and use
SE0401762D0 (en) Novel compounds
TW200714598A (en) Urea derivatives, methods for their manufacture, and uses therefor
DE602004024213D1 (en) Aminopropanolderivate
MY135850A (en) Ring-substituted diphenylazetidinones, process for their preparation, medicaments comprising these compounds and their use
SI1831239T1 (en) A process for the preparation of 17-hydroxy-6 beta, 7 beta, 15 beta, 16 beta -bismethylene-17 alpha-pregn-4-ene-3-one-21-carboxylic acid lambda-lactone and key-intermediates for this process
MY146802A (en) Novel drugs for treating respiratory diseases
TW200722418A (en) Novel compounds